These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11487026)

  • 1. Hemostatic risk factors for atherothrombotic disease: an epidemiologic view.
    Folsom AR
    Thromb Haemost; 2001 Jul; 86(1):366-73. PubMed ID: 11487026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue plasminogen activator antigen and D-dimer as markers for atherothrombotic risk among healthy postmenopausal women.
    Pradhan AD; LaCroix AZ; Langer RD; Trevisan M; Lewis CE; Hsia JA; Oberman A; Kotchen JM; Ridker PM
    Circulation; 2004 Jul; 110(3):292-300. PubMed ID: 15238458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The risk indices for atherothrombotic disease: the coagulation factors].
    Coccheri S
    Ann Ital Med Int; 1991; 6(4):408-15. PubMed ID: 1804286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemostasis and atherosclerosis.
    Warkentin TE
    Can J Cardiol; 1995 May; 11 Suppl C():29C-34C. PubMed ID: 7750046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fibrinogen and atherothrombosis: vulnerable plaque or vulnerable patient?].
    Jaeger BR; Labarrere CA
    Herz; 2003 Sep; 28(6):530-8. PubMed ID: 14569394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The investigation of a heart valve patient with suspected hypercoagulability.
    Gough SC; Prentice CR
    J Heart Valve Dis; 1993 Jan; 2(1):7-17. PubMed ID: 8269113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood coagulation, fibrinolysis and lipid profile in patients with primary hyperparathyroidism: increased plasma factor VII and X activities and D-Dimer levels.
    Erem C; Kocak M; Hacihasanoglu A; Yilmaz M; Saglam F; Ersoz HO
    Exp Clin Endocrinol Diabetes; 2008 Nov; 116(10):619-24. PubMed ID: 18484067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the immune system and inflammatory activity in relation to markers of atherothrombotic disease and atherosclerosis in rheumatoid arthritis.
    Wållberg-Jonsson S; Cvetkovic JT; Sundqvist KG; Lefvert AK; Rantapää-Dahlqvist S
    J Rheumatol; 2002 May; 29(5):875-82. PubMed ID: 12022343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrinolytic factors and atherothrombotic events: epidemiological evidence.
    Folsom AR
    Ann Med; 2000 Dec; 32 Suppl 1():85-91. PubMed ID: 11209988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemostatic factors, inflammatory markers, and progressive peripheral atherosclerosis: the Edinburgh Artery Study.
    Tzoulaki I; Murray GD; Price JF; Smith FB; Lee AJ; Rumley A; Lowe GD; Fowkes FG
    Am J Epidemiol; 2006 Feb; 163(4):334-41. PubMed ID: 16357107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemostatic tests in the prediction of atherothrombotic disease.
    Wu KK
    Int J Clin Lab Res; 1997; 27(3):145-52. PubMed ID: 9352376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemostatic and rheological variables and risk of cardiovascular disease.
    Lowe GD; Rumley A; Whincup PH; Danesh J
    Semin Vasc Med; 2002 Nov; 2(4):429-39. PubMed ID: 16222632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The need for risk factor assessment in atherothrombotic vascular disease.
    Lowe GD; Danesh J
    Semin Vasc Med; 2002 Aug; 2(3):231-2. PubMed ID: 16222615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fibrinogen: cardiovascular risk factor].
    Espinosa RA;
    Invest Clin; 2002 Dec; 43(4):291-301. PubMed ID: 12521001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of hemostatic risk factors in predicting arterial thrombotic events.
    Feinbloom D; Bauer KA
    Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2043-53. PubMed ID: 16100033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ankle-brachial index and hemostatic markers in the Atherosclerosis Risk in Communities (ARIC) study cohort.
    Reich LM; Heiss G; Boland LL; Hirsch AT; Wu K; Folsom AR
    Vasc Med; 2007 Nov; 12(4):267-73. PubMed ID: 18048462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombogenic risk factors for atherothrombosis.
    Shah PK
    Rev Cardiovasc Med; 2006; 7(1):10-6. PubMed ID: 16534491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statins in atherothrombosis.
    Colli S; Werba JP; Tremoli E
    Semin Vasc Med; 2004 Nov; 4(4):407-15. PubMed ID: 15861322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Common genetic variation in five thrombosis genes and relations to plasma hemostatic protein level and cardiovascular disease risk.
    Kathiresan S; Yang Q; Larson MG; Camargo AL; Tofler GH; Hirschhorn JN; Gabriel SB; O'Donnell CJ
    Arterioscler Thromb Vasc Biol; 2006 Jun; 26(6):1405-12. PubMed ID: 16614319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of the hemostatic system in pathogenesis of atherosclerosis as the main etiology of coronary ischemia] [corrected].
    Lisowski P; Małyszko J; Lisowska A; Czech B; Myśliwiec M; Jackowski R; Hirnle T
    Pol Merkur Lekarski; 2004 May; 16(95):465-7. PubMed ID: 15518428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.